Indonesia Pharmaceutical Industry



Ads

TANABE INDONESIA, PT
Address :
Head Office
Jalan Tanah Abang III/8
Jakarta 10160
DKI Jakarta
Phones – (021) 3841842 (hunting)
Fax. – (021) 3807550
Factory
Jalan Rumah Sakit 104
Ujung Berung
Bandung
West Java
Phones – (022) 7800001
Fax. – (022) 7800081

Tanggal Berdiri:
25 July 1970 as PT TANABE ABADI
2003 as PT TANABE INDONESIA
Legal Status :
PT (Limited Liability Company)

Pharmaceutical Industry
Category :
Foreign Investment (PMA) Company
P e r m i t s :
The President of the Republic Indonesia
No. B-146/BKPM/III/1970
Dated 25 March 1970
The Capital Investment Coordinating Board
– No. 35/II/PMA/89
Dated 28 June 1989
– No. 176/II/PMA/90
Dated 4 December 1990
– No. 6/II/PMA/2003
Dated 14 January 2003
– No. 558/III/PMA/2003
Dated 26 May 2003
The Department of Health
No. 4239/A/SK/PAB/71
Dated 16 June 1971

Lines of Business :
Pharmaceutical Industry
Production Capacity :
Initial
Pharmaceutical Product :
Capsules – 27.70 million pcs p.a.
Tablets – 84 million pcs p.a.
Syrups – 30 thousand pcs p.a.
Creams – 24 tons p.a.
Injections – 3 million vial p.a.
Beads – 1.22 million p.a.
Pharmaceutical Raw Material :
Diltiazem Hydro Chlorides – 12 tons p.a.
Expansion Unit
Aspartate Calcium – 100 tons p.a.
Herbeser – 46,400,000 tablets p.a.
Tanapress – 12,700,000 tablets p.a.
Adona – 33,500,000 tablets p.a.
Market / Pasar :
Export & Domestic
Capitalization :
Authorized Capital US$ 2,500,000
Issued Capital US$ 2,500,000
Paid Up Capital US$ 2,500,000
Shareholder (s) :
TANABE SEYAKU Co. Ltd., of Japan
PT. INTERCIPTA MITRA of Indonesia
Total Investment :
Equity Capital -US$ 2,500,000.-
Loan Capital -US$ 9,250,000.-
Total Investment -US$ 11,750,000.-
Banker(s) :
The Bank of TOKYO – MITSUBISHI UFJ Ltd.
Started Operation :
1970

Pharmaceutical Industry
Total Employees :
268 persons
Board of Management :
President Director – Mr. Ishak Mahdi
Vice President Director – Mr. Yoshifumi Mifune
Associated Companies :
NV PHARMACIE NASIONAL (Investment
Holding)
TANABE SEYAKU Co. Ltd., of Japan
(Investment Holding)
INTERCIPTA MITRA